0001171843-19-007390.txt : 20191108
0001171843-19-007390.hdr.sgml : 20191108
20191108174036
ACCESSION NUMBER: 0001171843-19-007390
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191106
FILED AS OF DATE: 20191108
DATE AS OF CHANGE: 20191108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cheung Sylvia
CENTRAL INDEX KEY: 0001572857
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 191205191
MAIL ADDRESS:
STREET 1: ANIKA THERAPEUTICS, INC.
STREET 2: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
ownership.xml
X0306
4
2019-11-06
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001572857
Cheung Sylvia
32 WIGGINS AVENUE
BEDFORD
MA
01730
0
1
0
0
Chief Financial Officer
Common Stock
2019-11-06
4
M
0
35000
6.36
A
71422
D
Common Stock
2019-11-06
4
F
0
3681
60.48
D
67741
D
Common Stock
2019-11-08
4
S
0
20000
59.71
D
47741
D
Stock Appreciation Rights
6.36
2019-11-06
4
M
0
35000
0
D
2020-01-26
Common Stock
35000
0
D
On November 6, 2019, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on May 7, 2019, Ms. Cheung exercised stock appreciation rights ("SARS") granted on January 26, 2010 vesting in four equal annual installments beginning January 26, 2011 and expiring on January 26, 2020.
Reflects 3,681 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on November 6, 2019.
On November 8, 2019, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on May 7, 2019, Ms. Cheung sold 20,000 shares in multiple trades ranging from $59.00 to $60.40, a portion of which sale covered the tax liability associated with the SARs exercise. The price reported above reflects the weighted average sale price. Ms. Cheung undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.
/s/ Sylvia Cheung
2019-11-08